Ben Fear’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
UK Director at Nyxoah in December 2024 - Present
Area Manager UK, Ireland, Nordics, Spain & Portugal at PRECISIS GmbH in October 2023 - December 2024
Director at Discreet Medical in June 2023 - October 2023
Director UK, Ireland & Nordics at Nevro in January 2023 - June 2023
Market Development Manager at Nevro in July 2022 - June 2023
Market Development Manager at Nevro in July 2022 - January 2023
Chief Executive Officer at P14 Medical Ltd in May 2021 - June 2022
Vice President P14 & Biowave LTD at P14 Medical Ltd in July 2020 - May 2021
Director UK & Ireland at Stimwave in July 2019 - July 2020
U.K. Country Manager at Stimwave in November 2018 - June 2019
Clinical Manager at Stimwave in April 2018 - October 2018
Senior Business Development Manager at Nevro in January 2018 - March 2018
Business Development Manager at Nevro in February 2014 - January 2018
Sales Representative at Stryker in January 2012 - January 2014
Sales Associate - North East at Stryker in October 2010 - January 2012
Precisis develops bioelectronic methods to direct therapeutic currents at defined target areas of the brain. AI-based learning models make it possible to activate or inhibit specific brain cells, depending on the condition to be treated. The unique achievement of the Precisis team has been to miniaturise bioelectric pacemakers for the brain and thereby make them so easily tolerable that patients will accept them as an integral part of their body. Not visible externally, the thin electrodes lend consistent support to the patient as though they were a natural means of protection against transmission malfunction in the brain. Precisis’ greatest success to date is EASEE® in the treatment of epilepsies. EASEE® is used to suppress epileptic seizures. With a minimally-invasive procedure, the thin electrode pad just gets slipped underneath the skin, onto the skull. It has received CE-mark for the treatment of focal epilepsies in September 2022 after two clinical trials showed tremendous efficacy and safety results. For more information click here: https://easee.precisis.de/en/ We at Precisis are a team of extraordinarily diverse personalities, passionate and committed. We all are sharing the same goal, which is to develop and market medical technology that reduces the burden of epilepsy and other neurological disorders. Join our Team! Check our website to learn more about your job opportunities: https://precisis.de/en/career/
Discover more about Nyxoah
Transkranielle fokale Kortexstimulation 🧠 bei medikamentenrefraktärer Epilepsie | Passion for Patients 🤝
Territory Manager at PRECISIS GmbH
(Aug 2025 – Present)
Vice President European Sales | Neuromodulation
Vice President European Sales at PRECISIS GmbH
(Jul 2025 – Present)
MedTech | Neuromodulation | Leadership
Director Sales & Clinical DACH at PRECISIS GmbH
(Jan 2024 – Present)
Managing Director and Chief Technology Officer (CTO) at Precisis AG
Managing Director and CTO at PRECISIS GmbH
(Oct 2024 – Present)
Head of QM/RA bei PRECISIS AG
Head of QM/RA at PRECISIS AG
(Oct 2015 – Present)
Experienced, proven medical industry specialist who is passionate about neuromodulation and the impact it can have on patients in the UK.
Senior Clinical Sales Manager UK at PRECISIS GmbH
(Feb 2025 – Present)
What is Ben Fear email address?
Email Ben Fear at [email protected] and [email protected]. This email is the most updated Ben Fear's email found in 2026.
How to contact Ben Fear?
To contact Ben Fear send an email to [email protected] or [email protected].
What company does Ben Fear work for?
Ben Fear works for Nyxoah.
What is Ben Fear's role at Nyxoah?
Ben Fear is UK Director
